Back to mobile site

Roth Capital Reiterates Buy on Trevena (TRVN) Following TRV130’s Phase 2b Results

September 1, 2015 9:41 AM EDT Send to a Friend
Roth Capital reiterated a Buy rating and $14.50 price target on Trevena (NASDAQ: TRVN) as the company announced that TRV130 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login